Clinical trial NCT06546124: Treatment of Upper Trapezius Muscle Myofascial Pain Syndrome
Official title: Treatment of Upper Trapezius Muscle Myofascial Pain Syndrome: Comparison of Ultrasound- Guided Dry Needling Techniques
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Myofascial Pain Syndrome
Lead sponsor: Abant Izzet Baysal University
Sponsor class: OTHER
First posted: 2024-08-09
Enrollment: 60
Sex: ALL
Minimum age (years): 20
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: The aim of this study is to compare the effects of superficial and deep dry needling techniques, guided by ultrasound, on pain, disability, functional impairment, and quality of life in patients diagnosed with myofascial pain syndrome of the upper trapezius muscle.

Detailed description: Myofascial Pain Syndrome (MAS) is a common condition encountered in the daily practice of musculoskeletal medicine. Dry needling is a commonly used technique by clinicians in the treatment of myofascial trigger points. Dry needling can be classified into two main categories based on the depth of needle insertion: superficial and deep dry needling. Dry needling can be performed using either manual palpation techniques or ultrasonographic imaging. Ultrasound allows for more precise needle placement. It must be recognized that the depth of needling (superficial insertion vs. deep insertion) varies for every structure and that without ultrasound guidance, differentiation between needling into the superficial fascia and beyond the deep fascia maybe difficult. In clinical settings, using ultrasound can help visualize the different layers and guide the needle to the appropriate depth. The aim of this study is to compare the effectiveness of deep fascia and intramuscular trigger point dry needling techniques, guided by ultrasound, on pain, disability, functional impairment, and quality of life in patients diagnosed with myofascial pain syndrome of the upper trapezius muscle.

Eligibility criteria: Inclusion Criteria:

1. Diagnosis of MPS in the upper trapezius muscle in accordance with criteria defined by Travell and Simons
2. Ages between 20 and 50 years
3. No treatment, including injections, dry needling, and physical methods, applied to the cervical region in the last three months

Exclusion Criteria:

1. Bleeding Tendency
2. History of Neck and Shoulder Trauma
3. Other Conditions Affecting Neck and Shoulder Pain: including malignancy, infection, rheumatic diseases, degenerative joint disease, fibromyalgia, cervical radiculopathy, neuropathy, myelopathy, myopathy, adhesive capsulitis, etc.
4. Cases Where Evaluation Could Not Be Completed for Any Reason
5. Patients Who Refuse to Complete the Evaluations

Primary outcomes:
measure: The Numerical Pain Rating Scale
timeFrame: Before treatment
measure: The Numerical Pain Rating Scale
timeFrame: 1 week after treatment
measure: Pressure Pain Threshold
timeFrame: Before treatment
measure: Pressure Pain Threshold
timeFrame: 1 week after treatment
measure: Neck disability index
timeFrame: Before treatment
measure: Neck disability index
timeFrame: 1 week after treatment
measure: Neck bournemouth questionnaire
timeFrame: Before treatment
measure: Neck bournemouth questionnaire
timeFrame: 1 week after treatment
measure: Joint range of Motion Measurement
timeFrame: Before treatment
measure: Joint range of Motion Measurement
timeFrame: 1 week after treatment
Secondary outcomes:
measure: Advers event
timeFrame: 1 week after treatment
measure: Cutaneous and subcutaneous thickness
timeFrame: Before treatment
Other outcomes:
Locations:
city: Bolu
country: Turkey
facility: Abant Izzet Baysal University
Study officials:
References: